Intensive
Take Strepsils Intensive when your throat is swollen or inflamed. It gives targeted relief that lasts for up to 4 hours thanks to anti-inflammatory action of Flurbiprofen.
Product Description
Strepsils Intensive is a medicated lozenge, that contains 8.75mg Flurbiprofen which has potent analgesic, antipyretic and anti-inflammatory properties. It relieves swollen or inflamed sore throats for up to 4 hours. Available in our popular Honey&Lemon flavour.
Ingredients
Each lozenge contains Flurbiprofen 8.75mg. Also contains: sucrose, glucose syrup, honey, macrogol 300, lemon flavour, potassium hydroxide, levomenthol. Each lozenge contains 2.5g carbohydrate.
Usage Information
Adults the elderly and children over the age of 12 years: One lozenge sucked/dissolved slowly in the mouth every 3 - 6 hours as required. Maximum 5 lozenges in a 24-hour period. It is recommended that this product should be used for a maximum of three days.
Children: Not indicated for children under 12 years.
Elderly: A general dose recommendation cannot be given, since to date clinical experience is limited. The elderly are at increased risk of the serious consequences of adverse reactions.
Impaired hepatic: In patients with mild to moderate impairment of hepatic function no dose reduction is required. In patients with severe hepatic insufficiency flurbiprofen is contraindicated.
Impaired renal: In patients with mild to moderate impairment of renal function no dose reduction is required. In patients with severe renal insufficiency flurbiprofen is contraindicate.
For oral administration and short-term use only. As with all lozenges, to avoid local irritation, Strepsils Intensive should be moved around the mouth whilst sucking. The lowest effective dose should be used for the shortest duration necessary to relieve symptoms
Consult healthcare professional before use if you are under medication. Keep all medicines out of the reach and sight of children.
Contraindications:
Hypersensitivity to flurbiprofen or any of the excipients in the product.
Patients who have previously shown hypersensitivity reactions (e.g. asthma, bronchospasm, rhinitis, angioedema, or urticaria) in response to acetylsalicylic acid or other NSAIDs.
Active or history of recurrent peptic ulcer/haemorrhage (two or more distinct episodes of proven ulceration) and intestinal ulceration.
History of gastrointestinal bleeding or perforation, severe colitis, haemorrhagic or haematopoietic disorders related to previous NSAID therapy.
Last trimester of pregnancy.
Severe heart failure, severe renal failure or severe hepatic failure.
For full list of Special warnings and precautions for use, please refer to the patient information leaflet (PIL).
Children: Not indicated for children under 12 years.
Elderly: A general dose recommendation cannot be given, since to date clinical experience is limited. The elderly are at increased risk of the serious consequences of adverse reactions.
Impaired hepatic: In patients with mild to moderate impairment of hepatic function no dose reduction is required. In patients with severe hepatic insufficiency flurbiprofen is contraindicated.
Impaired renal: In patients with mild to moderate impairment of renal function no dose reduction is required. In patients with severe renal insufficiency flurbiprofen is contraindicate.
For oral administration and short-term use only. As with all lozenges, to avoid local irritation, Strepsils Intensive should be moved around the mouth whilst sucking. The lowest effective dose should be used for the shortest duration necessary to relieve symptoms
Consult healthcare professional before use if you are under medication. Keep all medicines out of the reach and sight of children.
Contraindications:
Hypersensitivity to flurbiprofen or any of the excipients in the product.
Patients who have previously shown hypersensitivity reactions (e.g. asthma, bronchospasm, rhinitis, angioedema, or urticaria) in response to acetylsalicylic acid or other NSAIDs.
Active or history of recurrent peptic ulcer/haemorrhage (two or more distinct episodes of proven ulceration) and intestinal ulceration.
History of gastrointestinal bleeding or perforation, severe colitis, haemorrhagic or haematopoietic disorders related to previous NSAID therapy.
Last trimester of pregnancy.
Severe heart failure, severe renal failure or severe hepatic failure.
For full list of Special warnings and precautions for use, please refer to the patient information leaflet (PIL).
Code:
EA_8044692
Reference:
*Summary of Product Characteristics
1: Schachtel B, et al. Pain. 2014;155:422–428.